Huiyu Yuanhe (Hainan) Pharmaceutical Co., Ltd.

Primary objective: Using furosemide tablets (trade name: LASIX, specification: 20 mg) from Validus Pharmaceuticals LLC as the reference preparation and furosemide tablets (20 mg) developed by Huiyuyuanhe (Hainan) Pharmaceutical Co., Ltd. as the test preparation, a single-center, randomized, open, single-dose, two-preparation, two-cycle, two-sequence, crossover clinical trial was conducted to evaluate the bioequivalence of the two preparations in fasting and fed states in healthy Chinese subjects. Secondary objective: To observe the safety of the test preparation and the reference preparation in healthy Chinese subjects.